Galderma has unveiled a new global campaign, “Wake Up to Restylane,” positioning its Restylane hyaluronic acid filler portfolio as a go-to option for patients seeking subtle, natural-looking aesthetic results that fit seamlessly into everyday life. The campaign, announced January 29, 2026, at the IMCAS World Congress in Paris, reflects growing consumer interest in personalized injectable treatments that enhance facial balance and skin quality without appearing overdone.

According to Galderma, the “Wake Up to Restylane” campaign is designed to reframe dermal filler treatments from an occasional, event-driven procedure into an “always-on” beauty regimen. The messaging centers on patients waking up looking refreshed, rested, and confident, aligning with broader aesthetic trends favoring authenticity and understated enhancement rather than dramatic transformation.

Galderma, a global dermatology company and the maker of Restylane, introduced the campaign alongside new clinical data presented at IMCAS 2026. The company highlighted the versatility of the Restylane portfolio across multiple treatment areas, including the chin, jawline, temples, and décolletage. Galderma emphasized that Restylane is the only hyaluronic acid filler portfolio offering multiple technologies designed to support tailored treatment plans and natural movement with facial expressions.

“What’s compelling about ‘Wake Up to Restylane’ is its focus on beauty that’s ready when you are,” said Dr. Kuldeep Minocha, aesthetic physician at L’Art by Dr. M, in the announcement. “Patients increasingly want treatments that fit seamlessly into their lives, and this campaign captures that shift perfectly. For practitioners, Restylane continues to set the benchmark for HA treatments and remains an indispensable tool in modern aesthetic practice thanks to its proven science, unmatched versatility and reliability, and personalized, natural-looking results.”

Gerry Muhle, Galderma’s head of global product strategy, added that the campaign represents an evolution in how the brand connects with changing patient expectations, including first-time injectable patients who may be cautious about unnatural outcomes.

“Restylane has an iconic heritage as a trusted, science-backed HA treatment, and ‘Wake Up To Restylane’ is an exciting evolution in how we connect the brand with evolving beauty aspirations," said Muhle in the release. "We’re not just responding to change – we’re leading it – driving the category forward, including for those taking their first steps into aesthetics, while staying true to the authentic always-on beauty and personalization that define the brand."

Natural-looking results and the role of HA fillers

Hyaluronic acid fillers remain among the most requested aesthetic treatments in medical spas, with about a third of consumers ranking HA as their top injectable choice ahead of neuromodulators. According to Galderma's research, people describe HA treatments as an act of self‑care and self‑love, with many choosing HA to improve skin quality, seeking healthy, glowing, hydrated skin that looks refreshed. Patients and practitioners align on natural‑looking results, delivered safely and with reliable outcomes. This aligns perfectly with Restylane’s promise: authentic beauty that’s ready when you are, supported by three decades of safety data.

Galderma’s campaign dovetails with recent industry focus on patient demand for subtle, natural outcomes with hyaluronic acid fillers. Learn more about HA consumer sentiment: Achieving Natural Looking Results with HA Filler Treatments